Skip to main content

The most common breast cancer under siege




Press & Communications Section Head
Tel.+34 93 40 37255

The newspaper ABC has reported on a new project to be launched by IRB Barcelona researcher Roger Gomis thanks to a grant from the Fundación Fero Mango. Focusing on luminal breast cancer, one of the most common subtypes, the project aims to decipher the “dialogue” between tumour cells and bone stem cells. This information can then be used to design therapeutic targets and to limit the capacity of these cells to metastasize. “This is a groundbreaking approach to tackle metastasis in this kind of cancer,” says Gomis.

Beside, La Razón has reported on this project. In its article “Visionarios contra el cáncer”, it highlights that 15% of women with this type of tumour experience metastasis when healthy cells come into contact with cancer cells. “If we sever communication between these two types of cell, we will be able to stop metastasis. But to do this, we need to know how they communicate,” says the researcher.

Also,  the radio station Cadena SER´s programme, Hora 14 Catalunya,  has broadcasted an interview with Roger Gomis about this project 


Link to ABC

Link to: La Razón


mda_168195587.mp3 (312.99 KB)

About IRB Barcelona

The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).